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Abstract
Background: Radio-Adaptive Response (RAR) is a biological defense mechanism whereby exposure to low dose
ionizing radiation (IR) mitigates the detrimental effects of high dose irradiation. RAR has been widely observed in
vivo using as endpoint less induction of apoptosis. However, sex differences associated with RAR and variations
between males and females on global gene expression influenced by RAR have not been still investigated. In addition,
the response to radiation-induced apoptosis is associated with phosphorylation of TRP53 at both the serine 15 (ser-18
in the mouse) and serine 392 (ser-389 in mice) residues, but the role of these two phosphorylated forms in male and
female RAR remains to be elucidated.
Results: We analyzed the effect of administering priming low dose radiation (0.075 Gy of X-rays) prior to high dose
radiation (1.75 Gy of γ-rays) on the level of caspase-3-mediated apoptosis and on global transcriptional expression in
thymocytes of male and female mice. Here, we provide the first evidence of a differential sex effect of RAR on the
reduction of thymocyte apoptosis with males showing lesser levels of caspase-3-mediated apoptosis than females.
Analysis of transcriptomic profiles of 1944 genes involved in apoptosis signaling in radio-adapted thymocytes identified
17 transcripts exhibiting differential expression between both sexes. Among them, Dlc1 and Fis1 are closely related to
the apoptosis mediated by the TRP53 protein. Our data demonstrate that overexpression of Dlc1 and Fis1
occur concomitantly with a highest accumulation of phosphoserine-18-TRP53 and caspase-3 in radio-adapted
thymocytes of female mice. In an opposite way, both down-modulation of Fis1 and phosphoserine-389-TRP53
accumulation appear to be associated with protection from thymocyte apoptosis mediated by caspase-3 in males.
Conclusions: Transcriptomic analysis performed in this work reveals for the first time sex-specific differences in gene
expression influenced by RAR. Our results also suggest a sex-dependent dual role for phosphoserine-18-TRP53 and
phosphoserine-389-TRP53 in the regulation of the radio-adaptive response in mouse thymocytes.
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Background
The biological effects induced by exposing mammalian
cells to ionizing radiation (IR) are closely associated with
radiation doses and dose rates. Epidemiological evidence
indicates that exposures of 0.2 to 3 Gy increase risk to
cancer proportionally to the radiation dose received [1].
However, low dose radiation (<0.1 Gy) may result in a
complex scenario of cellular responses that are either
protective or supra-lethal according to the dose [2].
Radio-adaptive response (RAR) is a biological defense
mechanism whereby a low dose of ionizing radiation
(priming dose) protects cells against the detrimental ef-
fects of a subsequent higher radiation dose (challenging
dose). This protective phenomenon was first demon-
strated in vitro by Wolf and colleagues in 1984, who
showed that human peripheral blood lymphocytes irradi-
ated with tritiated thymidine had fewer chromosomal
aberrations when they were subsequently irradiated with
a high dose of X-rays [3]. RAR in human lymphocytes
was later analyzed in vitro in a series of studies
[reviewed in [4]]. Radioadaptation can be observed by a
reduction of certain deleterious genetic effects related to
DNA damage such as chromosomal aberrations, micro-
nuclei formation, gene mutations, and DNA single- and
double-strand breaks or by accelerated DNA repair [for
review, see [5]]. In mammalian cells, induction of RAR
requires a priming dose range of 0.01–0.2 Gy using low-
LET (Linear Energy Transfer) radiation (X- or γ-rays)
[6]. Furthermore, these cells need a time interval of 4–6
hours between the priming and the challenging doses to
reach the full induction of radioresistance [7].
In vivo RAR has been investigated by whole-body X-ray
exposure of male mice, using induction of apoptosis in
splenocytes as the biological endpoint [8–10]. These stud-
ies demonstrated that reduction of apoptosis after the con-
ditioning dose of X-rays may also be a hallmark of RAR.
Additional investigations showed that less induction of
apoptosis is closely associated with enhanced expression of
the transformation related TRP53 protein in spleen cells of
mice exposed to an acute single treatment with priming
low dose irradiation prior to a subsequent high dose irradi-
ation [11]. In contrast, primary cultures of mouse em-
bryonic fibroblasts from Trp53 knockout mouse were
refractory to RAR in terms of decreasing the percentage
of apoptotic cells [12]. Altogether, this evidence highlights
a requirement of the Trp53 gene in the induction of RAR.
It is well documented that DNA damage triggers a de-
fensive cellular signaling response mediated by the
Trp53 gene [13]. Activation of human TRP53 protein in
response to DNA damage induced by ionizing radiation
occur concomitantly with phosphorylation at both the
serine 15 and serine 392 (serine 18 and 389 in mouse
TRP53) residues [14]. Phosphorylation of the human
TRP53 protein at serine 15 (serine 18 in the murine
TRP53) is a key event that rapidly occurs in response to
radiation-induced DNA damage, thus contributing to its
stabilization and functional activation as transcription
factor by preventing MDM2 (a regulator of TRP53) from
binding and by rendering TRP53 resistant to MDM2
[15]. For its part, modification of the phosphorylation
site in TRP53 at serine 392 (homologue site of serine
389 in mouse TRP53) induces activation of site-specific
DNA binding and tetramerisation, as prerequisites for
its transcriptional activity [16, 17].
Cell type is one of the most important determinants of
the Trp53-mediated cellular outcome [18], and the
Trp53 gene is required for radiation-induced apoptosis
in mouse thymocytes [19]. A significant increase in the
apoptosis index in thymocytes appeared after exposure
of male mice to high or even low doses of whole-body
γ-irradiation 6 h following the end of treatment [20]. In
an opposite way, male mice receiving a low dose of
0.075 Gy priming X-irradiation administered 6 h prior to
a high dose of 1–2 Gy of X-rays showed a reduction of
apoptosis in thymocytes compared to males receiving
high dose X-irradiation alone [21]. Still, there are no re-
ports showing gender differences in apoptosis of radio-
adapted thymocytes.
Transcriptional profiling is a sensitive way to study the
effects of low dose radiation exposure [22, 23]. However,
only one study has so far investigated global expression
patterns after in vitro exposure to an adaptive regimen
of radiation in three human lymphoblastoid cell lines,
demonstrating down-modulation of apoptotic genes as-
sociated with RAR [24].
In this study we tested three hypotheses: (a) Exposure
of thymocytes to acute low dose radiation (priming dose)
prior to an acute high dose exposure (challenge dose) in-
duces a differential apoptotic response in male and fe-
male mice; (b) sex-specific changes in the transcriptional
expression of apoptosis-associated-genes induced by the
priming dose occur in radio-adapted thymocytes; and (c)
differences in apoptosis associated to RAR between
sexes are related with variations in phosphorylation
levels of TRP53 at serine 18 and serine 389.
Methods
To test these hypotheses, several experimental ap-
proaches have been performed in thymocytes from male
and female C57BL/6J mice (Fig. 1). First, caspase-3
amounts were estimated by Western blot to analyze the
effect of administering priming low dose radiation prior
to a high dose, as well as exposure to a single low or
high dose of radiation, on the level of apoptosis. Second,
we investigated by cDNA microarray analysis the tran-
script profiles of 1944 genes involved in apoptosis signal-
ing (included in the Agilent Mouse Gene Expression G3
8x60K microarray) according to GO-Ontology database
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under the mentioned experimental conditions. Third,
quantitative real-time reverse transcription polymerase
chain reaction (RT-PCR) analysis was used to validate
significant data from cDNA microarray analysis. Fi-
nally, protein amounts of phosphorylated forms of
TRP53 at serine 18 and serine 389 were determined
by Western blot in response to the adaptive regimen
of radiation and after exposure to single low or high
dose of radiation.
Mice and irradiation
Male and female C57BL/6J mice were purchased from
the Charles River Laboratories and kept 1 week in the
local animal house for acclimatization. Animal experi-
ments were carried out according to the European Com-
mission Guidelines (Directive 86/609/CEE) on the use of
laboratory animals.
Three groups of Irradiated males and females of com-
parable age (4 to 5 weeks) and weight (21–24 g) were
used in this study: group subjected to an adaptive regi-
men of radiation (RAR group), low dose exposed group
and group subjected to high dose exposure. Each experi-
mental group consisted of three individuals. Mice from
RAR group were irradiated with a priming dose of
0.075 Gy of X-rays, that it is known to known to induce
an effective in vivo radiaodaptive response in mouse thy-
mocytes [21], generated with a Philips MCN 101 X-ray
generator operating at 100 kV/15 mA with 1 mm of Be
and 3 mm AI added filtration. With an interval of 6 h,
that it has been used for radio-adaptive studies with thy-
mocytes [21], these mice were further irradiated with
challenging dose of 1.75 Gy of γ-rays that were generated
by a 137Cs gamma IBL-437C irradiator (CIS bio inter-
national, Gif-sur-Yvette, France). Mice from low dose ir-
radiation group were exposed to a single dose of X-rays
(0.075 Gy). Mice from high dose irradiation group were
treated with 1.75 Gy of γ-rays alone. Control group con-
sisted of non-irradiated mice.
Thymic cell fractionation
Mouse thymus samples were mechanically dispersed and
strained through a Nylon Mesh Cell Strainer of 40 μM
(BD Biosciences, San Jose, CA) to isolate the thymocytes.
Apoptosis analysis
Since pro-caspase 3 is cleaved into the 17–19 kDa and
12 kDa subunits only when cells undergo apoptosis, we
used the fragmentation of caspase 3 as indicator of
apoptosis induction. Cleaved caspase 3 (17/19 kDa) were
determined by Western blotting and assessed by densi-
tometry analysis.
Transcriptome analysis
cDNA microarray experiments were performed using
the Agilent Mouse Gene Expression G3 8x60K chip
(Agilent Technologies, Palo Alto, CA). Three independ-
ent thymocyte samples for each experimental condition
were used in this analysis. Total RNA was extracted by
combination of Trizol reagent (Invitrogen, Carlsbad,
CA), MaXtract high density extraction column (Qiagen,
Hilden, Germany) and purification using the RNeasy
Mini kit (Qiagen). Following extraction, total RNA were
checked for RNA integrity (Agilent 2100 Bioanalyzer,
Agilent Technologies). All samples showed common
high quality RNA Integrity Numbers (RIN 9.0–9.6) and
RNA was quantified by photometric measurement
using a Nanodrop ND-1000 spectrophotometer (Thermo
Scientific, Wilmington, DE, USA). A pool of amplified
RNAs obtained from the Universal Mouse RNA (Strata-
gene, La Jolla, CA) was used as a reference. Briefly, 100 ng
of total RNA was converted to cDNA, followed by in vitro
transcription and incorporation of Cy5-dCTP (test) and
Cy3-dCTP (reference) into nascent cRNA. After fragmen-
tation, labeled cRNA was hybridized to Agilent SurePrint
G3 Mouse GE 8x60K Microarrays for 17 h at 65 °C. Qual-
ity control parameters of cRNA labeling and hybridization
performance were found within the manufacturers specifi-
cations. Arrays were scanned as described by the
Apoptosis analysis
Caspase-3 protein amounts (Western blot)
GO-ONTOLGY analysis
Selection of apoptotic genes in 
Agilent Mouse Gene Expression G3 8x60K Chip  
cDNA microarray analysis
of 
apoptotic genes selected  
Transcriptome analysis
Analysis of TRP53 and its phosphorylated  
forms at serine 18 and serine 389
Protein amounts (Western blot)
Fig. 1 Signal cascade diagram showing working plan to test the
proposed hypotheses
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manufacturer. Signal intensities on 20 bit tiff images were
calculated by Feature Extraction software (FE, Vers.
10.7.1.1; Agilent Technologies, Palo Alto, CA). Normal-
ized signal values were then obtained by Cy5/Cy3 ratio
computing and logarithmic base 2 transformations with
the GeneSpring GX12 software (Agilent). Before statistical
analysis, a new quality control was performed to filter out
questionable and outlier expression values. Anyone nor-
malized expression value across the samples in each ex-
perimental condition that was further away from the
average, was ruled out considering it as an outlier.
GO Ontology analysis
In this study, we analyzed only those genes related with
apoptosis included in the mentioned cDNA microarray
(see Additional file 1: Table S1). For this purpose, we se-
lected genes that almost one of the GO Ontology identi-
fiers associated in the Agilent microarray annotation
data was included in a list of 387 GO-IDs related with
apoptosis in the Gene Ontology database of the annota-
tion data package “GO.db” (GO.db: A set of annotation
maps describing the entire Gene Ontology. R package
version 3.1.2. Carlson M. http://bioconductor.org). This
list of apoptosis GO-IDs was created from the total
number of GO identifiers registered in this database
(38027), selecting those GO-Terms-Name (TERM) or
GO-Term-Definition (DEF) included the words “apoptosis
and/or apoptotic process” (Additional file 2: Table S2).
Quantitative real-time reverse transcription polymerase
chain reaction (RT-PCR) analysis
Total RNA was extracted using Trizol reagent (Invitrogen)
according to the manufacturer’s instructions. Extracted
RNAs were then quantified using a Nanodrop ND-1000
spectrophotometer (Thermo Scientific, Wilmington, DE,
USA). Reverse transcription was performed using 1 μg of
total RNA for cDNA synthesis with the High Capacity
RNA-to-cDNA reverse transcription kit (Applied Bio-
systems, Foster City CA, USA) using random oligo-
nucleotide primers. All the quantitative real-time PCR
were carried out in 10 μl volume on ABI 7900HT Real-
Time PCR system (Applied Biosystems, Carlsbad, CA)
into 384-well plates using GoTaq qPCR Master Mix
(Promega, Madison, WI). Amplicons were designed to
span intron-exon boundaries. Primer efficiencies were
calculated prior to experimental use and amplification
efficiencies were greater than 90 % for all primer sets.
Amplifications using specific primers (Additional file 3:
Table S3) were done with a denaturation step at 95 °C
for 2 min, followed by 40 cycles of denaturation at 95 °C
for 3 s and primer annealing at 59 °C for 30 s. Upon com-
pletion of the cycling steps, a final step at 95 °C for 15 s,
60 °C for 15 s, and 95 °C for 15 s was done and then the
reaction was stored at 4 °C. Reactions were run in
triplicate in three independent experiments. The geomet-
ric mean of housekeeping genes HPRT1 and PPIA were
used as an internal control to normalize the variability in
expression levels and were analyzed using the 2-ΔΔCT
method described elsewhere [25].
Western blot analysis
Isolated thymocytes were homogenized in radioimmuno-
precipitation assay (RIPA) lysis buffer supplemented
with PhosStop phosphatase inhibitor and Complete
EDTA free protease inhibitors (Roche Molecular Bio-
chemicals, Mannheim, Germany). The concentrations of
thymocytes proteins were measured using a Pierce BCA
Protein assay kit (ThermoFisher Scientific, Wilmington,
DE) and a Benchmark Microplate Reader (Bio-Rad,
Hercules, CA). Proteins (5 μg) were mixed in equal
volume with 2× sample buffer (0.125 mol/l Tris-HCl,
4 % SDS, 20 % glycerol, 10 % 2-mercaptoethanol,
0.002 % bromophenol blue, pH 6.8). These samples
were boiled at 99 °C for 5 min, and immediately
cooled on ice. Electrophoresis was performed using
4–15 % Mini-PROTEAN TGX™ precast gels (BioRad,
Hercules, CA). The proteins of electrophoresed gels
were transferred to a polyvinylidene difluoride mem-
brane (PVDF) (Millipore, Temecula, CA). The sizes of
proteins were confirmed with the Precision Plus Pro-
tein Dual Color Standards (Bio-Rad).
After blocking, membranes were incubated with each
primary antibody in either 5 % w/v BSA or nonfat dry
milk, 1× TBS, 0.1 % Tween 20 overnight at 4 °C. As pri-
mary antibodies, p53 (1C12) (#2524; Cell Signaling),
caspase-3 (Asp175) (#9661; Cell Signaling), and phospho-
p38MAPK (Thr180/Tyr182) (#9211; Cell Signaling) were
used at 1:1000 dilution. For β-actin (A 5316; Sigma) was
used a dilution of 1:5000. Phospho-p53 (Ser15) (#9284;
Cell Signaling) and phospho-p53 (Ser392) (#9281; Cell
Signaling) were used at 1:500. Membranes were washed
with TBST buffer and incubated for 60 min at room
temperature with secondary antibodies we used Anti-
rabbit IgG, HRP-linked Antibody (#7074; Cell Signaling)
and Anti-mouse IgG, HRP-linked Antibody (#7076; Cell
Signaling) at 1:1000 dilution. Bound antibodies were
visualized by chemiluminescence using WesternBright™
ECL detection kit reagent (Advansta, Menlo Park, CA).
Luminescent images were analyzed using ImageQuant
LAS 4000 biomolecular imager analyzer (GE Healhcare,
Buckinghamshire, UK). For densitometry analysis Scion
Image software (Scion Corporation) analyzer program
was used.
Statistical analysis
cDNA microarray data analysis
To find sex differences in the transcriptional expression of
genes involved in apoptosis signaling that are influenced
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by RAR, male and female transcriptional expression were
compared under all experimental conditions by perform-
ing the statistical contrasts as follows: contrast 1 (male
RAR vs female RAR); contrast 2 (male RAR - female
RAR) vs (male control - female control); contrast 3(male
RAR - female RAR) vs (male high dose irradiation - female
high dose irradiation); and contrast 4 (male RAR - female
RAR) vs (male low dose irradiation - female low dose ir-
radiation). For those genes differentially expressed in all
the contrasts, the difference between their expressions in
male and female in RAR radiation condition is significant
from any other difference found in any other radiation or
control condition. These genes were selected as endpoints
of this analysis.
The log-transformed (base 2) normalized values of ex-
pression from cDNA microarray experiments were used
as the source of all raw data for statistical analysis in this
section, and to detect differentially expressed genes in
the contrasts described before, moderated t-test analysis
was conducted with functions of the limma Package
(R statistical software). P values were adjusted by the
Benjamini-Hochberg method to control false discovery
rate (FDR). And to consider a gene as differentially
expressed, results from moderated t-test should show
a FDR <0.05, and there should be an expression fold-
change (FC) ≥1.5.
Additionally, to assess sex differences in gene expres-
sion taking into account at the same time the effect of
the radiation treatment used, a two way ANOVA ana-
lysis was also applied.
Analysis of RT-PCR data
Mean expression values of selected genes were also cal-
culated by quantitative real-time RT-PCR between RAR
and the control condition in each sex, and compared
using t-tests.
Analysis of protein expression data
To assess the sex differences across the experimental
groups in protein amounts detected by Western blot
analyses, multivariate linear regression models were per-
formed including normalized mean values obtained from
three independent experiments as the outcome, and sex,
type of radiation treatment and an interaction term be-
tween them as independent variables.
Correlation coefficient analysis
Pearson product-moment correlation coefficients and
their statistical significance were calculated to assess the
strength and the direction of the associations between
expressions.
All statistical analyses were performed using R Software
(R Core Team (2013). R: A language and environment for
statistical computing. R Foundation for Statistical Com-
puting, Vienna, Austria. URL http://www.R-project.org/).
Results
Priming low dose radiation prior to high-dose radiation
induced differential apoptotic rates in thymocytes of male
and female mice
We first analyzed the levels of apoptosis by measuring
the amounts of caspase-3 protein in thymocytes of male
and female C57BL/6 mice irradiated with an acute single
dose of 0.075 Gy of X-rays or 1.75 Gy of γ-ray, and those
treated with 0.075 Gy of priming X-rays followed in 6 h
by 1.75 Gy of challenging γ-rays (hereafter referred as
adaptive regimen of radiation) (Fig. 2). According to the
multivariate regression model described in the Material
and Methods section, we found significant differences in
caspase-3 protein amounts for all radiation treatments
relative to non-irradiated controls (Table 1). Moreover,
there is an interaction between sex and treatment. In the
particular case of RAR, the difference in the levels of
Fig. 2 Dissimilar adaptive response of thymocyte apoptosis induced by priming low dose X-ray irradiation in C57BL/6 male and female mice. a
Representative results of the Western blotting assay for the expression of caspase-3. HIGH indicates exposure to 1.75 Gy of γ-rays. RAR represents
radio-adaptive response. LOW denotes exposure to 0.075 Gy of X-rays. b Quantitative analysis of caspase-3 protein levels. Amounts of caspase-3
were first normalized to β-actin, and then the ratio of each normalized value to its corresponding non-irradiated control value was calculated.
Histograms represent the mean ± SD of normalized values obtained from three independent experiments. Open columns, non-irradiated thymocytes.
Light gray columns, thymocytes exposed to 1.75 Gy of γ-rays. Dark gray columns, thymocytes treated with priming low dose X-irradiation (0.075 Gy)
6 h before a challenging high dose of γ-rays (1.75 Gy). Black columns, thymocytes exposed to 0.075 Gy of X-rays
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caspase-3-induced apoptosis between radio-adapted thy-
mocytes and non-irradiated thymocytes was higher in fe-
males as compared with males (Table 1).
Microarray analysis identified apoptotic genes with
differential expression in thymocytes of male and female
mice exposed to the adaptive regimen of radiation
To explore sex-specific differences on global gene ex-
pression associated to RAR we carried out transcrip-
tomic profiling in thymocytes of radioadapted males and
females by analyzing cDNA probes from 1944 genes
involved in apoptosis signaling (included in the Agilent
Mouse Gene Expression G3 8x60K) according to GO-
Ontology database. This analysis revealed that significant
differential expression for 17 genes (log2FC >1.5, adjusted
p-value (FDR) <0.05) in radio-adapted thymocytes of males
as compared to females (Table 2). Moreover, according
with the results of the two way ANOVA, the difference in
the expression of these 17 genes between males and fe-
males depend on the radiation treatment used (Table 2).
The 17 genes selected and shown in Table 2 were
grouped in two clusters of differentially expressed genes.
Table 1 Multivariate analysis of caspase 3 protein expression
Gene Variable Value Estimate t value p value p value*
Caspase 3 Sex Female ref 1.010E-09
Male −6.559E-03 −0.043 0.966
Treatment Control ref <2.2E-16
High 5.502 36.221 <2E-16
RAR 2.592 17.062 1.090E-11
Low 3.651 24.040 5.520E-14
Sex*Treatment Male(Control)*Female(Control) ref 9.483E-08
Male(High)*Female(High) −1.752 −8.156 4.310E-07
Male(RAR)*Female(RAR) −1.829 −8.513 2.450E-07
Male(Low)*Female(Low) −0.221 −1.029 0.319
Sex*Treatment interaction term between sex and radiation treatment, ref reference value, Estimat e regression coefficient, t value t test values; p value* p value
from F test in ANOVA analysis, High exposure to 1.75 Gy of g-rays, RAR radio-adaptive response, Low exposure to 0.075 Gy of X-rays
Table 2 Genes involved in apoptosis signaling that show differential transcriptional expression between male and female
radioadaptive thymocytes
Probe Name Gene Symbol Gene description log2FC FDR
a FDRb GO.Ontology
A_51_P449995 C6 Complement component 6 −1.64 9.89E-03 2.75E-02 GO:0006919
A_51_P458451 Adipoq Adiponectin 2.36 2.51E-03 3.76E-03 GO:0033034
A_51_P473170 Tnfsf4 Tumor necrosis factor superfamily member 4 2.06 1.67E-04 2.61E-03 GO:0043066
A_52_P304720 Crlf1 Cytokine receptor-like factor 1 −1.97 1.54E-03 4.64E-03 GO:0043524
A_52_P442710 Ndnf Neuro-derived neurotrophic factor 2.18 2.20E-04 2.06E-03 GO:0043524
A_52_P464831 Dlx1 Distal-less homeobox 1 −2.45 1.50E-04 4.61E-03 GO:0043524
A_55_P1952533 Fis1 Fission 1 (Mitochondrial Outer Membrane) Homolog (S. Cerevisiae) −2.94 1.06E-04 9.86E-04 GO:0001836
A_55_P1974019 Dapk1 Death associated protein kinase 1 2.18 9.38E-04 7.94E-03 GO:0008624
A_55_P1974845 Pde1a Phosphodiesterase 1A, Calmodulin-Dependent −2.24 2.46E-04 3.24E-03 GO:0034391
A_55_P1977431 Cck Cholecystokinin 1.79 2.67E-04 2.45E-03 GO:0005044
A_55_P1982400 Scara5 Scavenger Receptor Class A, Member 5 −2.91 1.72E-04 3.91E-03 GO:0005044
A_55_P2042101 Prune2 Prune Homolog 2 (Drosophila) −2.17 2.67E-04 6.68E-03 GO:0006917
A_55_P2044143 Loxl4 Lysyl Oxidase-Like 4 −2.29 4.37E-05 3.99E-04 GO:0005044
A_55_P2089710 Ednrb Endothelin Receptor Type B 2.57 4.02E-04 1.69E-02 GO:0043066
A_55_P2144686 Dmbt1 Deleted In Malignant Brain Tumors 1 2.78 2.61E-05 2.46E-03 GO:0005044
A_55_P2268221 Arhgap10 Rho GTPase Activating Protein 10 −2.49 2.54E-04 3.04E-03 GO:0043066
A_55_P2280821 Dlc1 Deleted in liver cancer 1 −2.53 2.02E-05 4.49E-04 GO:0006919
log2FC log2 Fold Change in gene expression between male and female under RAR treatment; a minus sign denotes down-regulation in radioadapted thymocytes
of males as compared with females; FDRa FDR obtained from the moderated t-test for identifying differentially expressed genes between male and female RAR,
FDRbFDR obtained from two-way ANOVA for assessing gene expression differences between male and female regarless treatment
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One composed by 10 genes that displayed a significant
reduction in their transcript levels in males relative to fe-
males (including among others the pro-apoptotic genes
C6, Dlc1, Fis1, Loxl4, Prune2 and Scara5), whereas an
inverse pattern was observed for the remaining seven
genes (including the anti-apoptotic genes Adipoq, Cck,
Dmbt1, Ednrb, Ndnf and Tnfsf4). These findings are con-
sistent with the lesser levels of apoptosis observed in
radio-adapted thymocytes of males as compared to those
of females.
Notably, two of the 17 genes that showed sex-
dependent transcriptional variations in radio-adapted
thymocytes, Fis1 and Dlc1, are closely related to Trp53-
mediated apoptosis. Like Trp53, the Fis1 gene participates
in apoptosis induced by caspase 3 by acting directly at
mitochondria [26]. Meanwhile, Dlc1 is a transcription tar-
get of TRP53 [27] that is also involved in caspase-3-
mediated apoptosis [28]. However, if we compare the
levels of expression of these genes between RAR and the
control situation, we found a significant differential ex-
pression of Fis1 in both sexes with increased expression in
females (log2FC = 1.97 and FDR = 0.0004) and reduced
mRNA transcript levels in males (log2FC = −1.60, and
FDR =0.001), while up-regulation of Dlc1 expression was
detected exclusively in the case of females (log2FC = 2.35,
FDR = 0.00001). Quantitative real-time RT-PCR analyses
(using primers showed in Additional file 3: Table S3)
showed overexpression of Fis1 (mean ± SD = 2.88 ± 0.19,
t = 18.73, P <0.0001) and Dlc1 (mean ± SD = 4.36 ± 0.26,
t = 30.79, P <0.0001) in radio-adapted thymocytes of fe-
males compared to control samples, and down-modulation
of Fis1 (mean ± SD= 0.82 ± 0.06, t = −4.71, P = 0.003) in
thymocytes of radio-adapted males relative to controls.
Sex differences in the phosphorylation levels of TRP53
protein at serine 18 and serine 389 in radio-adapted
thymocytes
Given that the predominant regulation of Trp53 oc-
curs at the post-translational level [29], it was not
surprising that transcriptome analysis did not detect
significant differences in the Trp53 gene expression
levels between radio-adapted thymocytes of males and
females (Table 2). Thus, we analyzed TRP53 protein
and its phosphorylated form at serine 18 under our
experimental conditions. TRP53 protein expression in
radio-adapted thymocytes was almost identical to that
found in the control group (Fig. 3a-b). However,
phosphoserine-18-TRP53 expression was strikingly
increased in thymocytes exposed to the adaptive regi-
men of radiation (Fig. 3c-d) and the multivariate analysis
showed significant sex differences in the expression of
phosphoserine-18-TRP53 in radio-adapted thymocytes
relative to controls, being these increases higher in fe-
males than in males (Table 3). Given that there seems
to be a relationship between the levels of phosphoryl-
ation of TRP53 at serine 18 and the induction of
apoptosis in response to ionizing radiation [30], we
wanted to find out whether these two variables were
correlated in radio-adapted thymocytes. Correlation
analysis demonstrated that phosphoserine-18-TRP53
accumulation associated with increased amounts of
caspase-3 protein in both males (r = 0.998, t = 21.0855,
df = 1, P = 0.03) and females (r = 0.9995, t = 31.6768,
df = 1, P = 0.02).
In addition, highest increases in the phosphorylation
levels of TRP53 at serine 389 were detected in thymocytes
of mice exposed to adaptive regimen of radiation com-
pared to non-irradiated thymocytes (Fig. 3e-f). Once more,
we also observed gender differences in radio-adaptive
thymocytes with males showing significant higher
levels of phosphoserine-389-TRP53 expression than
females (Table 3). Finally, we found an inverse rela-
tionship with a significant correlation between amounts of
caspase-3 protein and levels of phosphoserine-389-TRP53
in radio-adapted thymocytes of males (r = −0.99993,
t = −87.7847, df = 1, P = 0.007) and females (r = −0.9995,
t = −31.6768, df = 1, P = 0.02). These results suggest a pro-
tective effect against apoptosis for phosphoserine-389-
TRP53 induced by RAR with a differential response
between both sexes.
To confirm these latter results, we analyzed the phos-
phorylation levels of p38 mitogen activated protein
kinase (p38MAPK) on threonine 180 and tyrosine 182
residues, since previous in vitro studies have demon-
strated that such activated form of p38MAPK physically
associates with TRP53 to directly phosphorylate serine
389 [31]. Expression of activated-p38MAPK protein was
parallel to the amount of phosphoserine-389-TRP53,
with significant highest levels of activated-p38Mapk
detected in radio-adapted thymocytes of male mice as
compared to those of females (Fig. 3g-h; Table 3). In
fact, a significant high correlation was observed be-
tween levels of phosphoserine-389-TRP53 and activated-
p38MAPK in radio-adapted thymocytes of males (r =
0.99976, t = 46.5361, df = 1, P = 0.013) and females (r =
0.99979, t = 49.2148, df =1, P = 0.012).
Discussion
In this study, we provide the first evidence of a sex-
dependent protective effect of administering a single
priming low dose of X-rays against the detrimental ef-
fects of a subsequent high dose γ-irradiation exposure,
manifested by a reduced level of caspase-3-mediated
apoptosis in thymocytes. The fact that radio-adapted thy-
mocytes of males and females display a differential effect
against apoptosis suggests the existence of sex-specific
genetic factors associated with protection from apoptosis.
These differences may be related to the expression of the
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pro-apoptotic genes Dlc1 [28] and Fis1 [26], since we have
observed transcriptional up-regulation of Dlc1 and Fis1 in
thymocytes of female mice upon the adaptive regimen of
radiation whereas significant down-regulation of Fis1 was
found in male radio-adapted thymocytes.
The TRP53 protein regulates the transcription of many
different genes in response to a wide variety of stress sig-
nals, being Dlc1 one of these Trp53-responsive genes [27].
Upon activation, TRP53 regulates the transcription of
Trp53-responsive genes [32]. It has been demonstrated
Fig. 3 Different protein levels of phosphoserine-18-TRP53, phosphoserine-389-TRP53 and activated-p38MAPK after priming low dose X-ray irradiation
in thymocytes of C57BL/6 male and female mice. Left panels, representative Western blots. HIGH indicates exposure to 1.75 Gy of γ-rays. RAR represents
radio-adaptive response. LOW denotes exposure to 0.075 Gy of X-rays. Right panels, quantitative data showing normalized relative protein amounts.
Each column represents mean of three independent experiments; bars, SD. Open histograms, non-treated thymocytes. Light gray histograms,
thymocytes exposed to high dose (1.75 Gy) γ-irradiation. Dark gray histograms, thymocytes exposed to the adaptive regimen of radiation.
Black histograms, thymocytes treated with low dose X-irradiation (0.075 Gy). a-b, TRP53. c-d Phosphorylated form of TRP53 at serine 18. e-f
Phosphoserine-389-TRP53. g-h Phospho-(Thr180/Tyr182)-p38MAPK
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Table 3 Multivariate analysis of TRP53, phosphoserine-18-TRP53, phosphoserine-389-TRP53 and p38MAPK protein expression
Gene Variable Value Estimate t value p value p value*
TRP53 Sex Female ref 0.1805
Male −0.028 −0.305 0.764249
Treatment Control ref 1.033E-10
High 1.02 11.110 6.23e-09
RAR 0.438 4.779 0.000205
Low 0.787 8.590 2.18e-07
Sex*Treatment Male(Control)*Female(Control) ref 0.2020
Male(High)*Female(High) 0.104 0.800 0.435191
Male(RAR)*Female(RAR) −0.183 −1.417 0.175527
Male(Low)*Female(Low) −0.065 −0.501 0.623391
phosphoserine-18-TRP53 Sex Female ref 0.0004246
Male −0.126 −0.979 0.3420
Treatment Control ref <2.2E-16
High 13.57 105.038 <2E-16
RAR 9.49091 73.469 <2E-16
Low 12.67 98.071 <2E-16
Sex*Treatment Male(Control)*Female(Control) ref 7.153E-11
Male(High)*Female(High) 0.516 2.825 0.0122
Male(RAR)*Female(RAR) −2.101 −11.498 3.81e-09
Male(Low)*Female(Low) 0.947 5.185 9.03E-05
phosphoserine-389-TRP53 Sex Female ref 1.133E-05
Male 0.058 0.854 0.406
Treatment Control ref <2.2E-16
High 4.041 59.194 <2E-16
RAR 7.419 108.665 <2E-16
Low 7.739 113.354 <2E-16
Sex*Treatment Male(Control)*Female(Control) ref <2.2E-16
Male(High)*Female(High) 1.748 18.102 4.43E-12
Male(RAR)*Female(RAR) 0.909 9.416 6.30E-08
Male(Low)*Female(Low) −2.035 −21.076 4.26E-13
phospho-Thr 180/Tyr 182-p38MAPK Sex Female ref 1.196E-05
Male 4.586E-16 0.000 1.0000
Treatment Control ref 1.368E-15
High −1.923e-01 −1.918 0.0732
RAR 1.291 12.874 7.38E-10
Low −1.535e-01 −1.531 0.1453
Sex*Treatment Male(Control)*Female(Control) ref 3.259E-08
Male(High)*Female(High) −1.257e-01 −0.886 0.3886
Male(RAR)*Female(RAR) 1.348 9.507 5.53E-08
Male(Low)*Female(Low) 2.765E-02 0.195 0.8479
Sex*Treatment interaction term between sex and radiation treatment, ref reference value, Estimat e regression coefficient, t value t test values, p value* p value
from F test in ANOVA analysis, High exposure to 1.75 Gy of g-rays, RAR radio-adaptive response, Low exposure to 0.075 Gy of X-rays
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that TRP53-serine 15 phosphorylation plays a critical role
in stimulating transactivation at Trp53-responsive pro-
moters [33]. Furthermore, TRP53 upregulates human
DLC1 promoter activity in a dose-dependent manner [27].
Interestingly, we found higher levels of TRP53 phosphoryl-
ation at serine 18 in female radio-adapted thymocytes as
compared to those of males. Therefore, different amounts
of phosphoserine-18-TRP53 might explain, at least in part,
variations in Dlc1 expression that exists in both sexes.
However, the exclusive overexpression observed in radio-
adapted thymocytes of females suggests additional suggests
additional explanations. Investigators have found that
TRP53-mediated regulation of promoters may be influ-
enced by the existence of non-functional TRP53-binding
sites [34]. In this scenario, it is conceivably to speculate
that differences in the number of functional TRP53 re-
sponsive elements in the Dlc1 promoter of females and
males might affect differentially to its expression.
It is known that the human DLC1 protein participates in
a signaling cascade which cleaves the precursor caspase-3
into caspase-3, thereby allowing it to induce apoptosis [28].
On the other hand, radiation-induced apoptosis of mouse
thymocytes, estimated by caspase-3 activation, was found
to be entirely dependent of the Trp53 gene, since it was ab-
sent in Trp53 knockout mice [35]. Here, we have demon-
strated that radio-adapted thymocytes of females show
higher amounts of caspase-3 when compared with those of
males. Altogether, our results support a role for Dlc1 in the
induction of TRP53-mediated apoptosis associated with
RAR in female thymocytes.
In this study, we demonstrated that up-regulation of Dlc1 in
radio-adapted thymocytes of females was accompanied by
overexpression of Fis1. Interestingly, thymocytes of male mice
exposed to the adaptative regimen of radiation showed signifi-
cant down-modulation of Fis1. It is known that down-
regulation of Fis1 powerfully inhibits cell death [26]. In
contrast, over-expression of Fis1 has been reported to induce
apoptosis by a mechanism which involves mitochondrial
fragmentation followed by the release of cytochrome c
[36]. Thus, less induction of caspase-3-mediated apoptosis
in male radio-adapted thymocytes might be influenced, at
least in part, by down-modulation of Fis1. On the other
hand, it has been reported that the mouse TRP53 protein
rapidly accumulates at mitochondria of thymocytes under-
going γ-radiation-induced caspase-3-mediated apoptosis
[35]. In the mitochondria, TRP53 directly induces
permeabilization of the outer mitochondrial membrane by
forming inhibitory complexes with the anti-apoptotic
BCLXL and BCL2 proteins, resulting in cytochrome c re-
lease and in caspase-3 activation by the intrinsic death
pathway [37]. Evidence derived from the analysis of human
cells showed that serine 392 phosphorylation (serine 389 in
murine TRP53) plays a critical role in the stability of TRP53
protein by inhibiting its nuclear export mechanism, but it is
not essential in transactivation [38]. Thus, highest increases
found in the amount of phosphorylated form of TRP53 at
serine 389 in male radio-adapted thymocytes might be hin-
dering the transport of TRP53 from nucleus to mitochon-
dria. This fact together with down-modulation of Fis1
would be causing an inhibitory effect on the release of cyto-
chrome c from the mitochondria, thereby reducing the
levels of caspase-3 and ultimately the induction of apoptosis
in males exposed to the adaptive regimen of radiation. In
an opposite way, overexpression de Fis1 might cooperate
with up-regulation of Dlc1 to sustain a stronger caspase 3-
mediated apoptotic response in radio-adapted thymocytes
of females.
Finally, our results reveal that both activated-p38MAPK
and phosphoserine-389-TRP53 are strongly correlated in
RAR. It has been reported that the p38MAPK inhibitor,
SB203850, blocked RAR but did not suppress apoptosis,
indicating that the adaptive response and apoptosis are
two complementary defense mechanisms via life-or-death
decisions [12]. This study also demonstrated a pivotal role
for TRP53 in channeling the radiation-induced double-
strand breaks (DBSs) into an adaptive repair pathway,
turning off the apoptotic signaling pathway. Our results
support this notion since we report highest protein
amounts of both p38MAPK and phosphoserine-389-
TRP53 in male radio-adaptive thymocytes, which have in
turn lowest levels of caspase-3-mediated apoptosis.
Conclusions
We have observed a differential radio-adaptive response
between male and female mice using as endpoint the in-
duction of apoptosis mediated by caspase-3 in thymocytes.
Radio-adaptive response in females was accompanied by
higher protein amounts of phosphoserine-18-TRP53 and
caspase-3 as compared with male RAR. We also found
that the pro-apoptotic Dlc1 and Fis1 genes are specifically
overexpressed in thymocytes of female mice exposed to
the adaptive regimen of radiation. In contrast, a protective
role against caspase-3-mediated apoptosis associated with
an increase in the phosphorylation levels of TRP53 at
serine 389 and down-modulation of Fis1 was demon-
strated in radio-adaptive thymocytes of male mice.
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